Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients

Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials

(2013) Francesco Giorgino et al.   Annals of the New York Academy of Sciences

Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance

(2013) Maciej Banach et al.   CURRENT PHARMACEUTICAL DESIGN

Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1

(2013) M. Albiero et al.   DIABETES

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

(2013) L. Meneghini et al.   DIABETES OBESITY & METABOLISM

Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?

(2013) Cyrus V. Desouza   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

(2012) Gian Paolo Fadini et al.   CIRCULATION RESEARCH

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETOLOGIA

Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes

(2011) S. S. Johnston et al.   DIABETES CARE

Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes-a randomized controlled trial

(2011) K. Esposito et al.   DIABETES OBESITY & METABOLISM

Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine

(2011) G. P. Fadini et al.   DIABETES OBESITY & METABOLISM

The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1 

(2010) G. P. Fadini et al.   DIABETES CARE

Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals

(2010) N. Gogitidze Joy et al.   DIABETES CARE

Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation: Putative mechanism for aggravating vascular disease in diabetes

(2010) R. J. Wright et al.   DIABETES CARE

Potential manipulation of endothelial progenitor cells in diabetes and its complications

(2010) G. P. Fadini et al.   DIABETES OBESITY & METABOLISM

The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

(2010) C. Nordin   DIABETOLOGIA

Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis

(2010) Gian Paolo Fadini et al.   PLoS One

Megatrials in type 2 diabetes. From excitement to frustration?

(2009) S. Del Prato   DIABETOLOGIA